- SU5214
-
- $47.00
-
2026-08-08
- CAS:186611-04-1
- Purity: 99.52%
- Supply Ability: 10g
|
| | SU 5214 Basic information |
| Product Name: | SU 5214 | | Synonyms: | SU 5214;SU-5214;SU5214;SU 5214;2H-Indol-2-one, 1,3-dihydro-3-[(2-methoxyphenyl)methylene]-;FLK-1,SU5214,Vascular endothelial growth factor receptor,VEGFR,SU4949,inhibit,VEGFR2,SU 4949,SU-5214,Inhibitor,EGFR,SU-4949;SU5214, 10 mM in DMSO;3-(2-METHOXYBENZYLIDENE)-3H-INDOL-2-OL;SU5214 ，S6809;SU4949 | | CAS: | 186611-04-1 | | MF: | C16H13NO2 | | MW: | 251.28 | | EINECS: | | | Product Categories: | | | Mol File: | 186611-04-1.mol |  |
| | SU 5214 Chemical Properties |
| Boiling point | 469.4±45.0 °C(Predicted) | | density | 1.238±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMF: 33 mg/ml; DMSO: 33 mg/ml; DMSO:PBS(pH 7.2) (1:3): 0.25 mg/ml | | form | A crystalline solid | | pka | 12.81±0.20(Predicted) | | color | White to yellow |
| | SU 5214 Usage And Synthesis |
| Uses | SU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A, SU5214, has IC50s of 14.8 μM (FLK-1) and 36.7 μM (EGFR), respectively[1]. | | IC 50 | Flk-1: 14.8 μM (IC50) | | References | [1] Tang et al. 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease. US5834504A. |
| | SU 5214 Preparation Products And Raw materials |
|